Riskpilot← Back to searchSign inGet full accessM Medical Consulting AB
ABActiveOrg 5591163307Svanegränd 2Other education n.e.c. · NACE 8559Est. 20171 employees
Revenue 2025
SEK 1,6M
+6% vs 2024
EBITDA margin
56.9%
-5% vs 2024
Equity ratio
49.3%
Financial strength
Net profit 2025
SEK 596K
-2% vs 2024
| Revenue | SEK 1,6M | +6% |
| EBITDA | SEK 885K | -5% |
| Net profit | SEK 596K | -2% |
| Total assets | SEK 3M | +23% |
| Equity | SEK 1,5M | +35% |
| Employees | 1 | — |
Legal name
M Medical Consulting AB
Org number
5591163307
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
21 juni 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsult tjänster inom hälso och sjukvård samt fastighets och värdepappershantering.
Address
Svanegränd 2
Email
maria@mmedicalconsulting.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 138 | 1 730 | 1 404 | 1 473 | 1 557 |
| Staff expenses | — | — | −161 | −139 | −325 |
| EBITDA | 233 | 702 | 901 | 931 | 885 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 233 | 702 | 901 | 931 | 885 |
| Net financials | −1 | −32 | 3 | −1 | −3 |
| Profit before tax | 233 | 506 | 673 | 780 | 762 |
| Tax | −54 | −111 | −143 | −171 | −166 |
| Net profit | 179 | 395 | 530 | 609 | 596 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 914 | 1 551 | 1 766 | 2 402 | 2 958 |
| Equity | 308 | 633 | 683 | 1 082 | 1 459 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 366 | 498 | 433 | 520 | 580 |
| Total debt | 366 | 498 | 433 | 520 | 580 |
EBITDA margin
56.9%
This company
15.8%
Market median
+260% vs market
20212025
Equity ratio
49.3%
This company
38.2%
Market median
+29% vs market
20212025
Return on equity
40.9%
This company
18.4%
Market median
+122% vs market
20212025
Net profit margin
38.3%
This company
8.1%
Market median
+373% vs market
20212025
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20212025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EM Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
EM Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of M Medical Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Maria Lindbäck | Chief Executive Officer | 0 companies |
| Emelie Maria Englund | Chief Executive Officer | 0 companies |
| Erik Olof Englund | Deputy Board Member | 0 companies |
| Jan Stefan Lindbäck | Deputy Board Member | 0 companies |